New stem cell combo targets brain relapse in lymphoma patients
NCT ID NCT07481669
First seen Mar 23, 2026 · Last updated May 08, 2026 · Updated 7 times
Summary
This study tests a stem cell transplant using a chemotherapy cocktail called TEAM for lymphoma patients whose cancer is likely to spread to the brain or spinal cord. About 45 adults who have already responded to initial treatment will receive their own stem cells after high-dose chemo. The goal is to see if this approach can keep the cancer away longer with fewer side effects than standard treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA PATIENTS WITH HIGH-RISK OF CENTRAL NERVOUS SYSTEM RELAPSE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
RECRUITINGHangzhou, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.